Profile: Pall Corp (PLL.N)
24 May 2013
Pall Corporation, incorporated on July 31, 1946, is a filtration, separation and purification company. The Company is a supplier of filtration, separation and purification technologies, principally made by the Company using its engineering capability and fluid management, filter media, and other fluid clarification and separations equipment for the removal of solid, liquid and gaseous contaminants from a variety of liquids and gases. The Company serves customers through two businesses globally: Life Sciences and Industrial. The Life Sciences business group is focused on developing, manufacturing and selling products to customers in the Medical, BioPharmaceuticals and Food & Beverage markets. The Industrial business group is focused on developing, manufacturing and selling products to customers in the Process Technologies, Aerospace and Microelectronics markets. On August 1, 2012, the Company sold certain assets of its blood collection, filtration and processing product line (the Blood Sale), which was a component of the Life Sciences segment to Haemonetics Corporation.
Life Sciences Segment
The Company's Life Sciences technologies facilitate the process of drug discovery, development, regulatory validation and production. They are used in the research laboratory, pharmaceutical, biotechnology and food and beverage industries and in hospitals at the point of patient care. Sales in the Medical, BioPharmaceuticals and Food & Beverage markets are made through direct sales and distributors. The Company's medical products help control the spread of infections in hospitals. The Company's breathing-circuit, intravenous and point-of-use Pall-Aquasafe water filters help protect people from these infections. The Company's cell therapy product portfolio provides enabling technologies for the regenerative medicine market.
The Company sells a line of filtration and purification technologies, appurtenant hardware and engineered systems primarily to pharmaceutical and biotechnology companies for use by them in the development and commercialization of chemically synthesized and biologically derived drugs, plasma and vaccines. The Company provides a range of advanced filtration solutions for each stage of drug development through drug production. Its filtration systems and validation services assist drug manufacturers through the regulatory process to commercialization. The Company's laboratory product line is used in areas, such as drug research and discovery, quality control testing and in environmental monitoring applications for a host of industries. In the Americas and Europe, laboratory products are sold to customers principally through the Company's distribution partner, VWR International. Within the Food & Beverage market, the Company serves the filtration needs of the beer, wine, dairy, alcohol-free beverage, bottled water, and food ingredient markets.
The Company competes with Merck KGaA, General Electric Company (GE), Teleflex Incorporated, Covidien plc, Intersurgical, Ltd, The Sartorius Group, 3M Purification, Pentair, Inc., Filtrox Group, Eaton Corporation and Parker Hannifin.
The Company provides enabling and process enhancing technologies throughout the industrial marketplace. This includes the Process Technologies, Aerospace and Microelectronics markets. Process technologies market consists of producers of energy, oil, gas, renewable and alternative fuels, electricity, chemicals and municipal water. The Company also sells filtration solutions to the Machinery & Equipment submarkets, which consist of a grouping of producers of mobile equipment and trucks, pulp and paper, mining, automotive and metals. The part of this submarket is in emerging regions, such as the Middle East, North Africa and Latin America. The Company sells filtration and fluid monitoring equipment to the aerospace industry for use on commercial and military aircraft, ships and land-based military vehicles. The drivers in this market include passenger air miles flown, military budgets, production of new military and commercial aircraft, and demand for new aircraft, particularly in countries such as Brazil, Africa, China and Australia.
The Company's products are sold to customers through a combination of direct sales to airframe manufacturers and other customers, including the United States military, and through the Company's distribution partner, Satair A/S, for the commercial aerospace aftermarket, such as sales to commercial airlines. The Company sells filtration and purification technologies for the semiconductor, data storage, fiber optic, advanced display, solar and materials markets. The Company provides a suite of contamination control solutions for chemical, gas, water, chemical mechanical polishing and photolithography processes.
The Company competes with 3M Purification, GE, Siemens, Pentair, Inc., Donaldson Company, Inc., Parker Hannifin Corporation, ESCO Technologies Inc., HYDAC International GmbH, CLARCOR Inc, Entegris, Inc. and Mott Corporation.
25 Harbor Park Drive
PORT WASHINGTON NY 11050